1. P1041: IMPACT OF FEDRATINIB ON SPLEEN VOLUME AND MYELOFIBROSIS SYMPTOMS IN PATIENTS WITH SUBSTANTIAL SPLENOMEGALY: POST HOC ANALYSES FROM THE JAKARTA AND JAKARTA2 TRIALS. (23rd June 2022) Authors: Kiladjian, J.-J.; Tefferi, A.; Passamonti, F.; Vannucchi, A.; Talpaz, M.; Cervantes, F.; Harrison, C. N.; Mesa, R. A.; Mascarenhas, J.; Schaap, N.; Verstovsek, S.; Devos, T.; Rose, S.; Zhang, J.; Sy, O.; Pardanani, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 931 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P700: TREATMENT-FREE REMISSION (TFR) AFTER DASATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) AND DEEP MOLECULAR RESPONSE (DMR): FINAL 5-YEAR RESULTS OF DASFREE. (23rd June 2022) Authors: Shah, N. P.; García-Gutiérrez, V.; Jiménez-Velasco, A.; Saussele, S.; Rea, D.; Mahon, F.-X.; Levy, M. Y.; Gómez-Casares, M. T.; Mauro, M. J.; Sy, O.; Martin-Regueira, P.; Lipton, J. H. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Sexuality and quality of life of the young woman with breast cancer in a Moroccan context: experience of the medical oncology department CHU Hassan II FEZ. (March 2017) Authors: Ouahbi, H.; El'emrabet, F.Z.; Amaadour, L.; Benhami, M.; Sy, O.; Benbrahim, Z.; Arifi, S.; Nejjari, C.; Mellas, N. Journal: Breast Issue: Volume 32(2017)Supplement 1 Page Start: S86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗